Amy Franke
Chief Tech/Sci/R&D Officer at SHATTUCK LABS, INC.
Profile
Amy Franke is currently the Vice President-Clinical Operations at Shattuck Labs, Inc. She previously worked as the Senior Director-Strategy & Planning at Labcorp Drug Development, Inc., Vice President-Clinical Operations at NervGen Pharma Corp., and Vice President-Clinical Operations at Aravive, Inc. Ms. Franke completed her undergraduate degree at the University of Michigan and her graduate degree at the University of Pennsylvania Medical Center.
Amy Franke active positions
| Companies | Position | Start |
|---|---|---|
| SHATTUCK LABS, INC. | Chief Tech/Sci/R&D Officer | 01/10/2022 |
Former positions of Amy Franke
| Companies | Position | End |
|---|---|---|
| ARAVIVE, INC. | Chief Tech/Sci/R&D Officer | 01/08/2022 |
| COVANCE INC. | Corporate Officer/Principal | - |
| NERVGEN PHARMA CORP. | Chief Tech/Sci/R&D Officer | - |
Training of Amy Franke
| University of Michigan | Undergraduate Degree |
| University of Pennsylvania Medical Center | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| SHATTUCK LABS, INC. | Health Technology |
| NERVGEN PHARMA CORP. | Health Technology |
| ARAVIVE, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
- Stock Market
- Insiders
- Amy Franke
